Clinical Trials · NCT00514917

A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Name: A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Terminated
Sponsor: Sanofi
Enrollment: 413
Start date: Jul 2007
Locations: 9 sites, 9 countries
Primary endpoint: Median Progression-Free Survival (PFS) in Intent-to-treat (ITT) Population

View Gonadorelin compound reference